Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
2023-11-15 18:55
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S shares surged after a key study backed the use of Wegovy, its blockbuster weight-loss drug,
2023-11-13 17:19
Astra Enters Obesity Drug Race, Trumpets Price Potential
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines and
2023-11-09 21:57
Bayer’s CEO Weighs Breakup in U-Turn for German Conglomerate
Bayer AG’s new chief executive said he’s weighing a breakup of the pharma and agriculture conglomerate, a move
2023-11-08 17:30
Sanofi Probed for Market Manipulation by French Authorities
French financial prosecutors are investigating Sanofi for alleged market manipulation. The preliminary probe opened in March involves alleged
2023-11-08 00:54
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:57
Pig Kidney Transplanted Into Human Shows Way to Wider Use
Doctors transplanted a pig’s kidney into a brain-dead man’s body where it continued to function normally, moving the
2023-08-16 23:51
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo
2023-08-09 01:52
CVS to Cut 5,000 Jobs Amid Shift Away From Retail Focus
CVS Health Corp. will cut 5,000 positions from its workforce to help cut costs as the drugstore chain
2023-08-02 00:16
Eye Disease Drugmaker’s Value Halved After Severe Reactions
Apellis Pharmaceuticals Inc. shares suffered their worst two-day drop on record after confirming reports that some patients experienced
2023-07-19 04:16
Medical Credit Cards Targeted by US for Piling Debt on Patients
Three federal agencies are looking into potentially predatory practices in medical-payment products such as credit cards and installment
2023-07-08 01:55
Biotech Cyteir’s Drug Flop Turns Into Boon for Investors on Cash Return
A little-known biotech company, Cyteir Therapeutics Inc., notched its best day ever — on the back of plans
2023-07-01 04:58